ロード中...
Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()
Prostate cancer is a leading cause of cancer death in men in developed countries. Once the tumor has achieved a castration-refractory metastatic stage, treatment options are limited with the average survival of patients ranging from two to three years only. Recently, new drugs for treatment of castr...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pergamon
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834152/ https://ncbi.nlm.nih.gov/pubmed/23792785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsbmb.2013.06.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|